Subtopic Deep Dive
Glomus Tumor Histopathology
Research Guide
What is Glomus Tumor Histopathology?
Glomus tumor histopathology examines the microscopic features, immunohistochemical markers, and differential diagnosis of benign and malignant glomus tumors in soft tissues per WHO classification.
Glomus tumors show uniform round cells with punched-out nuclei arranged around vessels, often positive for smooth muscle actin. Atypical variants exhibit infiltrative growth, mitoses, pleomorphism, and necrosis (Folpe et al., 2001, 632 citations). The 2020 WHO classification integrates these features with perivascular myoid tumors like myopericytoma (Sbaraglia et al., 2020, 925 citations). Over 20 key papers span 1949-2020.
Why It Matters
Accurate histopathology distinguishes glomus tumors from mimics like hemangiopericytoma and myopericytoma, guiding surgical excision over aggressive sarcoma therapy (Folpe et al., 2001; Mentzel et al., 2006). In deep locations or GI sites, it prevents misdiagnosis as leiomyosarcoma, impacting prognosis since benign glomus tumors rarely metastasize (Miettinen et al., 2002). WHO updates refine classification, improving therapeutic precision in rare soft tissue sarcomas (Sbaraglia et al., 2020).
Key Research Challenges
Distinguishing atypical variants
Atypical glomus tumors show deep location, infiltrative growth, mitoses >5/50 HPF, and necrosis, overlapping with malignancy criteria (Folpe et al., 2001). Differentiating from myopericytoma requires vascular pattern assessment (Granter et al., 1998). No standardized IHC panel exists for all cases.
GI glomus tumor classification
GI glomus tumors mimic stromal tumors, lacking peripheral glomus features like small cell size (Miettinen et al., 2002). Relationship to GIST or leiomyosarcoma remains debated (Appelman & Helwig, 1976). WHO integration poses diagnostic hurdles.
Perivascular tumor overlap
Glomus tumors overlap with hemangiopericytoma and myopericytoma in branching vessels and myoid cells (Mentzel et al., 2006; Stout, 1949). Fletcher's composite features complicate separation (Granter et al., 1998). Mitotic rate and atypia thresholds vary.
Essential Papers
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
Marta Sbaraglia, Elena Bellan, Angelo Paolo Dei Tos · 2020 · Pathologica · 925 citations
Mesenchymal tumours represent one of the most challenging field of diagnostic pathology and refinement of classification schemes plays a key role in improving the quality of pathologic diagnosis an...
Atypical and Malignant Glomus Tumors
Andrew L. Folpe, Julie C. Fanburg–Smith, Markku Miettinen et al. · 2001 · The American Journal of Surgical Pathology · 632 citations
Occasional glomus tumors display unusual features, such as large size, deep location, infiltrative growth, mitotic activity, nuclear pleomorphism, and necrosis. Although a small number of purported...
Myofibromatosis in Adults, Glomangiopericytoma, and Myopericytoma
Scott R. Granter, Kamran Badizadegan, Christopher D.�M. Fletcher · 1998 · The American Journal of Surgical Pathology · 382 citations
The clinicopathologic features of 24 tumors showing perivascular myoid differentiation are described. These included tumors with histologic features of "infantile-type" myofibromatosis occurring in...
Hemangiopericytoma.A study of twenty-five new cases
Arthur Purdy Stout · 1949 · Cancer · 370 citations
Gastrointestinal Glomus Tumors
Markku Miettinen, Edina Paál, Jerzy Lasota et al. · 2002 · The American Journal of Surgical Pathology · 333 citations
Glomus tumors usually occur in the peripheral soft tissues, but similar tumors have also been reported in the stomach and occasionally in the intestines. However, the relationship of these tumors t...
Myopericytoma of Skin and Soft Tissues
Thomas Mentzel, Angelo Paolo Dei Tos, Z Sápi et al. · 2006 · The American Journal of Surgical Pathology · 316 citations
Perivascular neoplasms comprise traditionally glomus tumor and hemangiopericytoma (HPC). Whereas glomus tumor represents a well-defined entity, the existence of HPC as a separate entity has been qu...
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, R. Lor Randall, Robert S. Benjamin et al. · 2016 · Journal of the National Comprehensive Cancer Network · 298 citations
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blo...
Reading Guide
Foundational Papers
Start with Folpe et al. (2001, 632 citations) for atypia criteria, then Granter et al. (1998, 382 citations) for myopericytoma overlaps, and Mentzel et al. (2006, 316 citations) for perivascular spectrum.
Recent Advances
Sbaraglia et al. (2020, 925 citations) for WHO classification updates integrating glomus tumors.
Core Methods
Histology: vascular cuffing, round cells; IHC: SMA, vimentin; criteria: size >1cm, mitoses, necrosis per Folpe (2001); WHO refinement (Sbaraglia 2020).
How PapersFlow Helps You Research Glomus Tumor Histopathology
Discover & Search
Research Agent uses searchPapers('glomus tumor histopathology WHO classification') to find Sbaraglia et al. (2020), then citationGraph reveals Folpe et al. (2001) as highly cited predecessor, and findSimilarPapers expands to Mentzel et al. (2006) on myopericytoma overlaps.
Analyze & Verify
Analysis Agent applies readPaperContent on Folpe et al. (2001) to extract atypia criteria, verifyResponse with CoVe cross-checks mitotic thresholds against Granter et al. (1998), and runPythonAnalysis plots size vs. mitosis scatter from 20+ papers using pandas for malignancy prediction trends; GRADE scores evidence as high for WHO criteria.
Synthesize & Write
Synthesis Agent detects gaps in IHC markers for GI glomus tumors via contradiction flagging between Miettinen et al. (2002) and Appelman (1976), then Writing Agent uses latexEditText for histopathological description, latexSyncCitations integrates 10 papers, and latexCompile generates a review section with exportMermaid for differential diagnosis flowchart.
Use Cases
"Extract mitotic rates and outcomes from atypical glomus tumor cases in Folpe 2001."
Analysis Agent → readPaperContent(Folpe et al. 2001) → runPythonAnalysis(pandas tabulate mitoses >5/50HPF vs. metastasis) → CSV table of 15 cases with survival stats.
"Write LaTeX section on glomus vs myopericytoma differential with citations."
Synthesis Agent → gap detection (Mentzel 2006) → Writing Agent → latexEditText(draft text) → latexSyncCitations(Granter 1998, Folpe 2001) → latexCompile → PDF with figure captions.
"Find code for glomus tumor IHC quantification from papers."
Research Agent → paperExtractUrls(Miettinen 2002) → paperFindGithubRepo → githubRepoInspect → Python script for actin staining intensity analysis from 5 repos.
Automated Workflows
Deep Research workflow scans 50+ glomus papers via searchPapers, structures WHO evolution report with GRADE grading from Sbaraglia (2020) to Folpe (2001). DeepScan's 7-step chain verifies atypia criteria: readPaperContent → CoVe → runPythonAnalysis on metrics. Theorizer generates hypothesis on myopericytoma-glomus spectrum from Mentzel (2006) contradictions.
Frequently Asked Questions
What defines glomus tumor histopathology?
Uniform round cells with punched-out nuclei around vessels, SMA-positive, per Folpe et al. (2001). Atypical features include >5 mitoses/50 HPF, necrosis, infiltrative growth.
What are main methods for diagnosis?
Histology shows vascular glomangioma pattern; IHC confirms SMA, collagen IV. Differential uses WHO criteria distinguishing from myopericytoma (Sbaraglia et al., 2020; Mentzel et al., 2006).
What are key papers?
Folpe et al. (2001, 632 citations) on atypia/malignancy; Sbaraglia et al. (2020, 925 citations) WHO update; Miettinen et al. (2002) on GI variants.
What open problems exist?
IHC standardization for atypical/deep variants; GI glomus-stromal tumor borders; mitotic threshold consistency across perivascular tumors (Folpe 2001; Granter 1998).
Research Soft tissue tumors and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Glomus Tumor Histopathology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Soft tissue tumors and treatment Research Guide